Dave Ricks | Chairman and Chief Executive Officer |
Josh Smiley | Chief Financial Officer |
Dan Skovronsky | President, Lilly Research Labs |
Enrique Conterno | President, Lilly Diabetes, Lilly USA |
Phil Johnson | Investor Relations |
Mike Harrington | General Counsel |
John Boris | SunTrust |
Chris Schott | JP Morgan |
Greg Gilbert | Deutsche Bank |
Andrew Baum | Citi |
David Risinger | Morgan Stanley |
Jami Rubin | Goldman Sachs |
Geoff Meacham | Barclays |
Jason Gerberry | Bank of America |
Steve Scala | Cowen |
Umer Raffat | Evercore |
Vamil Divan | Credit Suisse |
Louise Chen | Cantor Fitzgerald |
Hima Inguva | Bank of America Merrill Lynch |
Ladies and gentlemen, thank you for standing by. Welcome to the Q2 2018 Earnings Call. At this time, all participants are in a listen-only mode. [Operator Instructions] We do remind, today's call is being recorded. Replay information will be given out at the conclusion of the conference.